Entry Detail



General Information

Database ID:exR0000398
RNA Name:AHCY
RNA Type:mRNA
Chromosome:chr20
Starnd:-
Coordinate:
Start Site(bp):34280268End Site(bp):34311802
External Links:ENSG00000101444



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AASDHPPT
chr11
106075501
106098699
+
AASS
chr7
122073549
122144255
-
AATK
chr17
81110487
81166221
-
ABRACL
chr6
139028745
139043302
+
AC007192.1
chr19
18153158
18178117
+
AC008982.1
chr19
38817471
38840178
-
AC010422.3
chr19
12643831
12648397
-
AC011448.1
chr19
19516227
19536076
+
AC015813.2
chr17
57989038
58007246
-
AC087289.3
chr17
75898645
75930129
-
AC104109.3
chr5
134167170
134226071
-
AC105052.3
chr7
102637049
102671641
-
AC120057.2
chr17
7240427
7244635
-
ACAA2
chr18
49782164
49813953
-
ACAP1
chr17
7336529
7351477
+
ACKR3
chr2
236567787
236582354
+
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTR3
chr2
113890063
113962596
+
ADIPOR1
chr1
202940826
202958572
-
ADIPOR2
chr12
1688574
1788674
+
ADPRH
chr3
119579268
119589945
+
ADPRHL2
chr1
36088892
36093932
+
ADSL
chr22
40346500
40390463
+
AEN
chr15
88621337
88632281
+
AGO1
chr1
35869808
35930532
+
AL022238.4
chr22
40346529
40410054
+
AL359922.1
chr9
21802636
22029594
+
ALDH18A1
chr10
95605941
95656711
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005618.1
chr5
141326210
141329357
+
AC008443.1
chr5
181246507
181272167
+
AC016876.2
chr17
7581964
7584086
-
AC026362.1
chr12
122975320
122982907
+
AC067852.2
chr17
42552436
42554748
-
AC091564.2
chr11
6603642
6604420
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL035458.2
chr20
34234840
34281173
-
AL118516.1
chr22
46761894
46762563
-
AC135178.6
chr17
8277763
8278436
+
AP005263.1
chr18
9102736
9254346
+
CYTOR
chr2
87454781
87636740
+
DHRS4-AS1
chr14
23938219
24052555
-
ESRG
chr3
54632122
54639857
-
LINC00545
chr13
30880912
30883395
+
LINC00941
chr12
30755167
30802602
+
LINC01278
chrX
63222993
63561095
-
LINC01578
chr15
92819540
92899701
+
NOP14-AS1
chr4
2934882
2961738
+
SNHG14
chr15
24978583
25420336
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.